VanEck Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
1,172
-1,681
| -59% | -$2.87K | ﹤0.01% | 1386 |
|
|
2025
Q1 | $6K | Hold |
2,853
| – | – | ﹤0.01% | 1373 |
|
|
2024
Q4 | $16K | Buy |
2,853
+1,266
| +80% | +$7.1K | ﹤0.01% | 1349 |
|
|
2024
Q3 | $12K | Sell |
1,587
-1,266
| -44% | -$9.57K | ﹤0.01% | 1334 |
|
|
2024
Q2 | $20K | Hold |
2,853
| – | – | ﹤0.01% | 1326 |
|
|
2024
Q1 | $25K | Buy |
2,853
+529
| +23% | +$4.64K | ﹤0.01% | 1311 |
|
|
2023
Q4 | $15K | Buy |
2,324
+318
| +16% | +$2.05K | ﹤0.01% | 1338 |
|
|
2023
Q3 | $20K | Sell |
2,006
-167
| -8% | -$1.67K | ﹤0.01% | 1334 |
|
|
2023
Q2 | $27K | Buy |
2,173
+294
| +16% | +$3.65K | ﹤0.01% | 1340 |
|
|
2023
Q1 | $26K | Buy |
1,879
+198
| +12% | +$2.74K | ﹤0.01% | 1343 |
|
|
2022
Q4 | $24K | Sell |
1,681
-2,799
| -62% | -$40K | ﹤0.01% | 1350 |
|
|
2022
Q3 | $114K | Buy |
4,480
+1,621
| +57% | +$41.2K | ﹤0.01% | 1158 |
|
|
2022
Q2 | $81K | Buy |
+2,859
| New | +$81K | ﹤0.01% | 1252 |
|